These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 10555959

  • 1. Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy.
    Pellegrini M, Mierke DF.
    Biochemistry; 1999 Nov 09; 38(45):14775-83. PubMed ID: 10555959
    [Abstract] [Full Text] [Related]

  • 2. Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin A receptor.
    Giragossian C, Mierke DF.
    Biochemistry; 2001 Apr 03; 40(13):3804-9. PubMed ID: 11300760
    [Abstract] [Full Text] [Related]

  • 3. Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin-2 receptor.
    Giragossian C, Mierke DF.
    Biochemistry; 2002 Apr 09; 41(14):4560-6. PubMed ID: 11926817
    [Abstract] [Full Text] [Related]

  • 4. Conformational and molecular modeling studies of sulfated cholecystokinin-15.
    Giragossian C, Stone S, Papini AM, Moroder L, Mierke DF.
    Biochem Biophys Res Commun; 2002 May 10; 293(3):1053-9. PubMed ID: 12051766
    [Abstract] [Full Text] [Related]

  • 5. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
    Hadac EM, Ji Z, Pinon DI, Henne RM, Lybrand TP, Miller LJ.
    J Med Chem; 1999 Jun 17; 42(12):2105-11. PubMed ID: 10377216
    [Abstract] [Full Text] [Related]

  • 6. The role of segment 32-47 of cholecystokinin receptor type A in CCK8 binding: synthesis, nuclear magnetic resonance, circular dichroism and fluorescence studies.
    De Luca S, Ragone R, Bracco C, Digilio G, Tesauro D, Saviano M, Pedone C, Morelli G.
    J Pept Sci; 2003 Mar 17; 9(3):156-69. PubMed ID: 12675498
    [Abstract] [Full Text] [Related]

  • 7. Fluorescence studies on the binding between 1-47 fragment of cholecystokinin receptor CCK(A)-R(1-47) and nonsulfated cholecystokinin octapeptide CCK8.
    Ragone R, De Luca S, Tesauro D, Pedone C, Morelli G.
    Biopolymers; 2003 Mar 17; 56(1):47-53. PubMed ID: 11582577
    [Abstract] [Full Text] [Related]

  • 8. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.
    Kennedy K, Gigoux V, Escrieut C, Maigret B, Martinez J, Moroder L, Fréhel D, Gully D, Vaysse N, Fourmy D.
    J Biol Chem; 1997 Jan 31; 272(5):2920-6. PubMed ID: 9006937
    [Abstract] [Full Text] [Related]

  • 9. Ligand-induced internalization of cholecystokinin receptors. Demonstration of the importance of the carboxyl terminus for ligand-induced internalization of the rat cholecystokinin type B receptor but not the type A receptor.
    Pohl M, Silvente-Poirot S, Pisegna JR, Tarasova NI, Wank SA.
    J Biol Chem; 1997 Jul 18; 272(29):18179-84. PubMed ID: 9218453
    [Abstract] [Full Text] [Related]

  • 10. Differences in receptor binding and stability to enzymatic digestion between CCK-8 and CCK-58.
    Reeve JR, McVey DC, Bunnett NW, Solomon TE, Keire DA, Ho FJ, Davis MT, Lee TD, Shively JE, Vigna SR.
    Pancreas; 2002 Oct 18; 25(3):e50-5. PubMed ID: 12370550
    [Abstract] [Full Text] [Related]

  • 11. Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.
    Harikumar KG, Dong M, Cheng Z, Pinon DI, Lybrand TP, Miller LJ.
    Biochemistry; 2006 Dec 12; 45(49):14706-16. PubMed ID: 17144663
    [Abstract] [Full Text] [Related]

  • 12. NMR studies of CCK-8/CCK1 complex support membrane-associated pathway for ligand-receptor interaction.
    Giragossian C, Pellegrini M, Mierke DF.
    Can J Physiol Pharmacol; 2002 May 12; 80(5):383-7. PubMed ID: 12056543
    [Abstract] [Full Text] [Related]

  • 13. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, Fourmy D.
    Mol Pharmacol; 1994 Apr 12; 45(4):599-607. PubMed ID: 8183238
    [Abstract] [Full Text] [Related]

  • 14. Photoaffinity labeling of central cholecystokinin receptors with high efficiency.
    Thiele C, Fahrenholz F.
    Biochemistry; 1993 Mar 23; 32(11):2741-6. PubMed ID: 8457542
    [Abstract] [Full Text] [Related]

  • 15. Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones.
    Stone SR, Giragossian C, Mierke DF, Jackson GE.
    Peptides; 2007 Nov 23; 28(11):2211-22. PubMed ID: 17950490
    [Abstract] [Full Text] [Related]

  • 16. Determination of ligand-receptor interactions of cholecystokinin by nuclear magnetic resonance.
    Giragossian C, Mierke DF.
    Life Sci; 2003 Jun 27; 73(6):705-13. PubMed ID: 12801592
    [Abstract] [Full Text] [Related]

  • 17. Direct identification of the agonist binding site in the human brain cholecystokininB receptor.
    Anders J, Blüggel M, Meyer HE, Kühne R, ter Laak AM, Kojro E, Fahrenholz F.
    Biochemistry; 1999 May 11; 38(19):6043-55. PubMed ID: 10320330
    [Abstract] [Full Text] [Related]

  • 18. The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process.
    Escrieut C, Gigoux V, Archer E, Verrier S, Maigret B, Behrendt R, Moroder L, Bignon E, Silvente-Poirot S, Pradayrol L, Fourmy D.
    J Biol Chem; 2002 Mar 01; 277(9):7546-55. PubMed ID: 11724786
    [Abstract] [Full Text] [Related]

  • 19. On the biologically active structures of cholecystokinin, little gastrin, and enkephalin in the gastrointestinal system.
    Pincus MR, Carty RP, Chen J, Lubowsky J, Avitable M, Shah D, Scheraga HA, Murphy RB.
    Proc Natl Acad Sci U S A; 1987 Jul 01; 84(14):4821-5. PubMed ID: 3037525
    [Abstract] [Full Text] [Related]

  • 20. Anthranilic acid based CCK1 receptor antagonists and CCK-8 have a common step in their "receptor desmodynamic processes".
    De Luca S, Saviano M, Lassiani L, Yannakopoulou K, Stefanidou P, Aloj L, Morelli G, Varnavas A.
    J Med Chem; 2006 Apr 20; 49(8):2456-62. PubMed ID: 16610788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.